AGP Executive Report
Last update: an hour agoPediatric Heart Care: Providence Heart Institute has opened a children’s cardiac catheterization lab, offering minimally invasive heart procedures in a space designed for young patients. Menopause Care: ACOG issued its most comprehensive guidance yet, covering hormone, nonhormone and other options for hot flashes, sleep problems and mood symptoms. Drug Updates: The FDA cleared Enspryng for thyroid eye disease and expanded Anktiva’s use for a type of bladder cancer; Europe’s medicines committee also backed the oral weight-loss drug Foundayo. HIV Treatment: A 46-patient case series found long-acting lenacapavir plus cabotegravir maintained viral suppression, including among people facing housing instability. Screening & Prevention: Experts say cost, limited organized programs and smoking stigma are keeping eligible adults from lung cancer screening. Outbreak Watch: WHO urged vigilance in Kenya after a second Ebola case, as health authorities quarantine contacts and strengthen preparedness. Prescribing: A Cochrane review of 93 studies found pharmaceutical promotion can influence doctors’ prescribing, raising concerns about treatment choices and costs.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
![<![CDATA[ The Unique Considerations Mid-Sized Pharma Companies Face When Making MFN Deals]]>](https://2c717466dc25cd7041c9-8eeda6a8ca964cf210ed223dbc947813.ssl.cf2.rackcdn.com/29479793-950169651-30e8073b2dc0176507c7f29f8a3546cb19aa3b7a-1280x720-200x113.jpeg)
